TherapyLink.AI
TherapyLink.AI explores guided reflection and information flows for sensitive concerns. This case study explains the product design, privacy choices, and boundaries around uncertainty and human support.
Delivery status is not specified in this case study.
Sensitive questions are easy for a general chatbot to answer too broadly, too confidently, or without enough context. A useful product must protect privacy, avoid pretending to diagnose or treat, recognize uncertainty, and make it easy to stop or seek human support.
What makes it useful: Many wellness chatbots maximize open-ended conversation and blur responsibility. TherapyLink.AI narrows each interaction to consented tools, keeps privacy and escalation visible, and uses deterministic safety boundaries so helpful guidance cannot silently become diagnosis or treatment.
The intended value is a calm way to organize concerns and choose a next step. The case study presents a product and interaction design; it does not establish clinical benefit.
Edge AI is treated as the private first pass: local models summarize reflections, detect likely themes, route the user toward appropriate guided mini-app flows, and reduce cloud exposure for sensitive early-stage user data.
State a concern and choose what context to share.
Use the relevant reflection or information flow, with uncertainty and product limits visible.
Choose whether to continue, stop, or seek human support; sharing information requires a separate consent decision.
I designed TherapyLink.AI as an intent-routed web product rather than an open-ended therapy bot. It uses privacy-first local processing for early summarization and theme detection, then guides the user into bounded reflection, education, safety-check, or handoff flows with clear limits around what the software can and cannot do.
I designed focused reflection and information flows around the person’s stated intent. The architecture gives privacy choices, uncertainty, stopping, and human support explicit places in the interaction.
The OverLift method keeps intent, consent, privacy, uncertainty, safety checks, and human handoff boundaries explicit. Local models can help organize a reflection and route it toward an appropriate guided tool, while deterministic rules decide what the product may show, when it must stop, and when a person should be directed toward qualified human support.
The method is reusable. Each product supplies its own facts, rules, execution, and validation. These tiers describe the shared architecture; the project scope above records which capabilities are implemented here.
Why determinism matters here: Sensitive guidance must behave consistently at the safety boundary. Determinism ensures the same consent, risk, and escalation conditions produce the same allowed product behavior.
Define the authoritative result before adding acceleration, semantics, or agents.
Instrument state, latency, quality, and failure so improvement is observable.
Move expensive or high-frequency work behind clear worker and memory boundaries.
Version messages, snapshots, identities, deadlines, and replay inputs.
Let local retrieval and models propose meaning only inside admitted evidence.
Compare several allowed next actions with explicit risk, cost, fit, and uncertainty.
Challenge the production route without giving the challenger authority.
Promote only measured, replayable paths with fallback and operational receipts.
Run advanced evaluators in shadow, compare them with the control, and graduate only repeatable gains.
CATS chooses a qualified execution tier for the evidence, device, latency, permissions, and failure conditions of the task.
The Semantic Bridge maps a goal to explicit entities, evidence, uncertainty, tools, and permissions. Missing or contradictory information remains visible.
Models may retrieve, compare, or propose. Exact software checks facts, permissions, state changes, and execution, then records what happened.
The case study presents the intended guided experience, privacy approach, and human-support boundaries. It supplies no clinical outcome study or evidence that the software can replace professional care. The workflow below describes the product design.
